SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-021223
Filing Date
2017-11-02
Accepted
2017-11-02 16:21:57
Documents
56
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kpti-10q_20170930.htm 10-Q 1696290
2 EX-31.1 kpti-ex311_9.htm EX-31.1 8381
3 EX-31.2 kpti-ex312_7.htm EX-31.2 8419
4 EX-32.1 kpti-ex321_8.htm EX-32.1 6277
5 EX-32.2 kpti-ex322_6.htm EX-32.2 6374
  Complete submission text file 0001564590-17-021223.txt   5585753

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kpti-20170930.xml EX-101.INS 1222934
7 XBRL TAXONOMY EXTENSION SCHEMA kpti-20170930.xsd EX-101.SCH 39958
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20170930_cal.xml EX-101.CAL 37238
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20170930_def.xml EX-101.DEF 126015
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20170930_lab.xml EX-101.LAB 303938
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20170930_pre.xml EX-101.PRE 230804
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 171172688
SIC: 2834 Pharmaceutical Preparations